309 related articles for article (PubMed ID: 38504070)
1. Advances in tumor vascular growth inhibition.
Zhang K; Shi Y; Jin Z; He J
Clin Transl Oncol; 2024 Mar; ():. PubMed ID: 38504070
[TBL] [Abstract][Full Text] [Related]
2. Broad targeting of angiogenesis for cancer prevention and therapy.
Wang Z; Dabrosin C; Yin X; Fuster MM; Arreola A; Rathmell WK; Generali D; Nagaraju GP; El-Rayes B; Ribatti D; Chen YC; Honoki K; Fujii H; Georgakilas AG; Nowsheen S; Amedei A; Niccolai E; Amin A; Ashraf SS; Helferich B; Yang X; Guha G; Bhakta D; Ciriolo MR; Aquilano K; Chen S; Halicka D; Mohammed SI; Azmi AS; Bilsland A; Keith WN; Jensen LD
Semin Cancer Biol; 2015 Dec; 35 Suppl(Suppl):S224-S243. PubMed ID: 25600295
[TBL] [Abstract][Full Text] [Related]
3. Angiogenic signaling pathways and anti-angiogenic therapy for cancer.
Liu ZL; Chen HH; Zheng LL; Sun LP; Shi L
Signal Transduct Target Ther; 2023 May; 8(1):198. PubMed ID: 37169756
[TBL] [Abstract][Full Text] [Related]
4. Recent advances of nanomaterial-based anti-angiogenic therapy in tumor vascular normalization and immunotherapy.
Xiao M; Shi Y; Jiang S; Cao M; Chen W; Xu Y; Xu Z; Wang K
Front Oncol; 2022; 12():1039378. PubMed ID: 36523993
[TBL] [Abstract][Full Text] [Related]
5. Emerging applications of anti-angiogenic nanomaterials in oncotherapy.
Tang B; Ma W; Lin Y
J Control Release; 2023 Dec; 364():61-78. PubMed ID: 37871753
[TBL] [Abstract][Full Text] [Related]
6. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
Gacche RN; Meshram RJ
Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
[TBL] [Abstract][Full Text] [Related]
7. Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor.
Zhao Y; Adjei AA
Oncologist; 2015 Jun; 20(6):660-73. PubMed ID: 26001391
[TBL] [Abstract][Full Text] [Related]
8. Trends and Challenges in Tumor Anti-Angiogenic Therapies.
Jászai J; Schmidt MHH
Cells; 2019 Sep; 8(9):. PubMed ID: 31540455
[TBL] [Abstract][Full Text] [Related]
9. An Overview of Cancer Biology, Pathophysiological Development and It's Treatment Modalities: Current Challenges of Cancer anti-Angiogenic Therapy.
Al-Ostoot FH; Salah S; Khanum SA
Cancer Invest; 2024 Jun; ():1-46. PubMed ID: 38874308
[TBL] [Abstract][Full Text] [Related]
10. Angiogenesis in hepatocellular carcinoma: mechanisms and anti-angiogenic therapies.
Yao C; Wu S; Kong J; Sun Y; Bai Y; Zhu R; Li Z; Sun W; Zheng L
Cancer Biol Med; 2023 Jan; 20(1):25-43. PubMed ID: 36647777
[TBL] [Abstract][Full Text] [Related]
11. The Epigenetic Profile of Tumor Endothelial Cells. Effects of Combined Therapy with Antiangiogenic and Epigenetic Drugs on Cancer Progression.
Ciesielski O; Biesiekierska M; Panthu B; Vialichka V; Pirola L; Balcerczyk A
Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32283668
[TBL] [Abstract][Full Text] [Related]
12. Loss of apelin blocks the emergence of sprouting angiogenesis in experimental tumors.
Azad AK; Campbell KR; Zhabyeyev P; Oudit GY; Moore RB; Murray AG
FASEB J; 2022 Oct; 36(10):e22560. PubMed ID: 36165236
[TBL] [Abstract][Full Text] [Related]
13. Nano-targeting vascular remodeling in cancer: Recent developments and future directions.
Giordo R; Wehbe Z; Paliogiannis P; Eid AH; Mangoni AA; Pintus G
Semin Cancer Biol; 2022 Nov; 86(Pt 2):784-804. PubMed ID: 35257860
[TBL] [Abstract][Full Text] [Related]
14. The application and research progress of anti-angiogenesis therapy in tumor immunotherapy.
Tu J; Liang H; Li C; Huang Y; Wang Z; Chen X; Yuan X
Front Immunol; 2023; 14():1198972. PubMed ID: 37334350
[TBL] [Abstract][Full Text] [Related]
15. Anti-angiogenesis in cancer therapeutics: the magic bullet.
Oguntade AS; Al-Amodi F; Alrumayh A; Alobaida M; Bwalya M
J Egypt Natl Canc Inst; 2021 Jul; 33(1):15. PubMed ID: 34212275
[TBL] [Abstract][Full Text] [Related]
16. Combining Angiogenesis Inhibitors with Radiation: Advances and Challenges in Cancer Treatment.
Rani V; Prabhu A
Curr Pharm Des; 2021; 27(7):919-931. PubMed ID: 33006535
[TBL] [Abstract][Full Text] [Related]
17. 'Accidental' anti-angiogenic drugs. anti-oncogene directed signal transduction inhibitors and conventional chemotherapeutic agents as examples.
Kerbel RS; Viloria-Petit A; Klement G; Rak J
Eur J Cancer; 2000 Jun; 36(10):1248-57. PubMed ID: 10882863
[TBL] [Abstract][Full Text] [Related]
18. Targeting tumor vascularization: promising strategies for vascular normalization.
Zheng R; Li F; Li F; Gong A
J Cancer Res Clin Oncol; 2021 Sep; 147(9):2489-2505. PubMed ID: 34148156
[TBL] [Abstract][Full Text] [Related]
19. Tumor Angiogenesis and Anti-Angiogenic Strategies for Cancer Treatment.
Teleanu RI; Chircov C; Grumezescu AM; Teleanu DM
J Clin Med; 2019 Dec; 9(1):. PubMed ID: 31905724
[TBL] [Abstract][Full Text] [Related]
20. Nature's Elixir for Cancer Treatment: Targeting Tumor-induced Neovascularization.
Kumari R; Syeda S; Shrivastava A
Curr Med Chem; 2024 Feb; ():. PubMed ID: 38425113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
